19 May 2013
Keywords: Mercck & Co, AstrZeneca, Option agreement, Nexium, Prilosec
Article | 28 June 2012
US drug giant Merck & Co (NYSE: MRK) and Anglo-Swedish major AstraZeneca have amended the option agreement related to their ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 June 2012
27 June 2012
17 May 2013
© 2013 thepharmaletter.com